Atria Wealth Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.19M Sell
28,670
-18,984
-40% -$2.02M 0.07% 300
2025
Q1
$5.34M Sell
47,654
-10,807
-18% -$1.12M 0.06% 320
2024
Q4
$5.4M Sell
58,461
-2,703
-4% -$243K 0.06% 337
2024
Q3
$5.13M Sell
61,164
-13,757
-18% -$1.05M 0.06% 342
2024
Q2
$5.14M Sell
74,921
-751
-1% -$50.1K 0.06% 336
2024
Q1
$5.54M Sell
75,672
-4,823
-6% -$371K 0.06% 311
2023
Q4
$6.52M Buy
80,495
+338
+0.4% +$26.3K 0.08% 245
2023
Q3
$6.01M Buy
80,157
+207
+0.3% +$15.9K 0.08% 246
2023
Q2
$6.16M Sell
79,950
-8,233
-9% -$657K 0.08% 234
2023
Q1
$7.32M Sell
88,183
-3,655
-4% -$303K 0.11% 185
2022
Q4
$7.88M Buy
91,838
+2,599
+3% +$206K 0.13% 174
2022
Q3
$5.51M Buy
89,239
+26,994
+43% +$1.7M 0.1% 213
2022
Q2
$3.85M Sell
62,245
-22,003
-26% -$1.36M 0.08% 281
2022
Q1
$5.01M Buy
+84,248
New +$5.39M 0.08% 253

Other funds holding GILD